Brødkrumme Forside Vtesse Pharma Vtesse Pharma Developed VTS-270 to treat patients with Niemann-Pick Disease Type C. Lundbeckfonden BioCapital Investeringsår 2014 Acquired by Sucampo Pharmaceuticals in 2017 Lokation Gaithersburg, Maryland, USA